Major histocompatibility complex II (MHC II) dependent antigen presentation links CD4+ T cell activation to the initiation of adaptive immunity. In mature B lymphocytes, class II transactivator (CIITA) is the master regulator of MHC II transcription. During the transition from B cell to plasma cell, CIITA expression itself is transcriptionally silenced, which results in the loss of MHC II expression. This process constitutes a hallmark event during B cell differentiation and aberrant differentiation is associated B cell malignancy; the underlying mechanism, however, remains incompletely understood. Our preliminary data suggest that the transcriptional repressor HIC1 binds to the proximal promoter of CIITA and represses its transcription. In addition, HIC1 message levels are up-regulated during B cell differentiation. Therefore, we hypothesize that factors that drive B cell differentiation promote CIITA repression via activating HIC1. Our specific aims are to 1) unveil the mechanism whereby HIC1 represses CIITA transcription during B cell differentiation, and 2) the mechanism whereby HIC1 transcription is up-regulated during B cell differentiation. Our ultimate goal is to clarify the regulatory circuit that connects CIITA repression to B cell differentiation and to provide critical insights into the intervention and/or prevention of B cell lymphoma.
依赖于MHC II的抗原呈递是启动适应性免疫反应的必要步骤。在成熟的B细胞中,CIITA是决定MHC II转录激活的关键调控因子。在B细胞分化为浆细胞过程中,CIITA的表达在转录水平被抑制,从而导致MHC II水平下调。这一过程是B细胞分化的标志性事件,但其中的分子机制尚未阐明。B细胞分化异常在临床上导致B细胞淋巴瘤。我们前期的研究发现,转录抑制因子HIC1可以结合到CIITA的启动子上并抑制CIITA的转录。进一步的研究发现,HIC1的表达在B细胞分化过程中上调。因此,我们提出一个假说,即刺激B细胞分化的因素通过激活HIC1引起CIITA表达的沉默,最终实现从B细胞向浆细胞的分化。我们拟从1)HIC1介导CIITA转录抑制的机制和2)B细胞分化过程中HIC1表达上调的机制这两个方面来研究HIC1促使B细胞分化的机制,并为临床预防或治疗B细胞淋巴瘤提供有价值的线索。
依赖于MHC II的抗原呈递是启动适应性免疫反应的必要步骤。在成熟的B细胞中,CIITA是决定MHC II转录激活的关键调控因子。在B细胞分化为浆细胞过程中,CIITA的表达在转录水平被抑制,从而导致MHC II水平下调。这一过程是B细胞分化的标志性事件,但其中的分子机制尚未阐明。B细胞分化异常在临床上导致B细胞淋巴瘤。我们前期的研究发现,转录抑制因子HIC1可以结合到CIITA的启动子上并抑制CIITA的转录。我们拟研究HIC1介导CIITA转录抑制的机制,并为临床预防或治疗B细胞淋巴瘤提供有价值的线索。在项目研究期间,我们发现HIC1直接结合到CIITA启动子的近端(-298/-288)。HIC1过表达直接抑制B细胞中内源CIITA的转录而干扰HIC1则部分阻断B细胞分化中CIITA表达的下调。HIC1与DNMT1与DNMT3b互相作用并结合到CIITA的近端启动子上,引起DNA甲基化,从而抑制CIITA转录。干扰DNMT或使用DNMT抑制剂Aza-C部分缓解B细胞分化过程中CIITA的转录抑制。我们的研究证实,HIC1是一个全新的调控B细胞分化的转录因子。上述部分结果已经在国际期刊BBA-Gene Regul Mech上发表。
{{i.achievement_title}}
数据更新时间:2023-05-31
DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素
The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects
转录组与代谢联合解析红花槭叶片中青素苷变化机制
视网膜母细胞瘤的治疗研究进展
Bousangine A, a novel C-17-nor aspidosperma-type monoterpenoid indole alkaloid from Bousigonia angustifolia
INF-γ通过CIITA调控PPARγ转录机制及其在2型糖尿病中意义的探讨
PRMT1调控CIITA转录活性的机制研究及其生物学意义
核受体LXR调控树突状细胞分化的机制及其在肿瘤中的病理意义
转录因子EBF1在间充质干细胞调控B细胞分化治疗抗体介导排斥反应中的作用及机制